Scinai Immunotherapeutics(DE:2F50)
€2.260.00 (0.00%)
DE:2F50
Scinai Immunotherapeutics financials statements
€2.26
At close:0.00 (0.00%)
Scinai Immunotherapeutics (2F50) Income Statement
0 Followers
Scinai Immunotherapeutics Income Statement
Last quarter (Q3 2026), Scinai Immunotherapeutics's total revenue was $1.86M, an increase of 589.96% from the same quarter last year. In Q3, Scinai Immunotherapeutics's net income was $-1.97M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.31M | $ 658.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -2.65M | $ -580.00K | $ 0.00 | $ 0.00 | $ -747.65K | |
| $ 4.89M | $ 8.06M | $ 9.71M | $ 11.06M | $ 10.05M | |
| Depreciation and Amortization | $ 1.42M | $ 1.65M | $ 514.00K | $ 562.00K | $ 471.00K |
| $ -6.53M | $ -6.99M | $ -2.19M | $ -5.23M | $ -10.32M | |
| $ -7.54M | $ -8.64M | $ -9.71M | $ -11.06M | $ -10.79M | |
| $ -765.00K | $ 13.43M | $ 3.21M | $ 5.26M | $ -1.58M | |
| $ -8.31M | $ 4.80M | $ -6.50M | $ -5.80M | $ -12.38M | |
| $ -8.31M | $ 4.80M | $ -6.50M | $ -5.80M | $ -12.38M | |
| Per Share Metrics | |||||
| Basic EPS | $ -36.00 | $ 60.00 | $ -64000.00 | $ -160000.00 | $ -3507480.00 |
| Diluted EPS | $ -36.00 | $ 60.00 | $ -64000.00 | $ -160000.00 | $ -3507480.00 |
| Weighted Average Shares Outstanding | 233.49K | 80.64K | 97 | 47 | 3 |
| Weighted Average Shares Outstanding (Diluted) | 233.49K | 80.64K | 97 | 47 | 3 |
Currency in USD
